Monday, May 17, 2021

After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial

Title: After Setbacks, Sanofi/GlaxoSmithKline COVID Vaccine Performs Well in Early Trial
Category: Health News
Created: 5/17/2021 12:00:00 AM
Last Editorial Review: 5/17/2021 12:00:00 AM

from MedicineNet Daily News https://ift.tt/3oqq8Vv
via IFTTT

0 comments:

Post a Comment